MedPath

Comparison of ropivacaine and bupivacaine for spinal anaesthesia.

Not Applicable
Completed
Conditions
Health Condition 1: 8- Other Procedures
Registration Number
CTRI/2022/10/046717
Lead Sponsor
Bhabha Atomic Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients aged 18-60 years, ASA grade I-II undergoing elective infra-umbilical surgeries, less than 2hours, under spinal anaesthesia.

Exclusion Criteria

Patient refusal

Pregnancy

Allergy to local anesthetic drugs

Any other contra indications to spinal anaesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study duration of action of hyperbaric ropivacaine and hyperbaric bupivacaine.Timepoint: 24hours
Secondary Outcome Measures
NameTimeMethod
To study <br/ ><br>1.Time taken to achieve maximum sensory blockade. <br/ ><br>2.Time taken to achieve maximum motor blockade. <br/ ><br>3.Intra-operative hemodynamics. <br/ ><br>4.Time taken for 5 segment regression of sensory block. <br/ ><br>5.Time taken for regression of motor blockade to modified Bromage 1. <br/ ><br>6.Side effects if any <br/ ><br>Timepoint: 24hours
© Copyright 2025. All Rights Reserved by MedPath